K.W. Bock
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Glycosylation and Glycoproteins Research 2
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
- Epigenetics and DNA Methylation 1
- Oncology 6
- Cancer-related Molecular Pathways 4
- Co-authors
- Harry Schachter (1 shared paper)Jacques Magdalou (1 shared paper)Keith F. Tipton (1 shared paper)Mitchell Green (1 shared paper)Doron Lancet (1 shared paper)Alain Bélanger (1 shared paper)Pierre Louisot (1 shared paper)Takashi Iyanagi (1 shared paper)
- Journals
- Carcinogenesis (2 papers)Toxicology Letters (2 papers)Journal of Cancer Research and Clinical Oncology (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
K.W. Bock
14 papers receiving 1.3k citations
K.W. Bock's Hit Papers
Peers
Comparison fields: 5 of 95
- Pharmacology 475
- Cancer Research 170
- Pediatrics, Perinatology and Child Health 211
- Oncology 279
- Health, Toxicology and Mutagenesis 154
Countries citing papers authored by K.W. Bock
This map shows the geographic impact of K.W. Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.W. Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.W. Bock more than expected).
Fields of papers citing papers by K.W. Bock
This network shows the impact of papers produced by K.W. Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.W. Bock. The network helps show where K.W. Bock may publish in the future.
Co-authors
The 25 scholars most cited alongside K.W. Bock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence Hit paper breakdown → | 1997 | 1031 |
| 2 | 2000 | 56 | |
| 3 | 1995 | 50 | |
| 4 | 1995 | 38 | |
| 5 | 1993 | 34 | |
| 6 | 1991 | 34 | |
| 7 | 1996 | 30 | |
| 8 | 1974 | 26 | |
| 9 | 2002 | 20 | |
| 10 | 1995 | 18 | |
| 11 | 1989 | 7 | |
| 12 | 1990 | 6 | |
| 13 | 1978 | 5 | |
| 14 | 1974 | 2 |
About K.W. Bock
K.W. Bock is a scholar working on Molecular Biology, Oncology, Pharmacology, Cancer Research and Surgery, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Cancer-related Molecular Pathways (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Glycosylation and Glycoproteins Research (2 papers), Toxic Organic Pollutants Impact (2 papers), DNA Repair Mechanisms (1 paper), Ubiquitin and proteasome pathways (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Pharmacology (475 citations), Cancer Research (170 citations), Pediatrics, Perinatology and Child Health (211 citations), Oncology (279 citations) and Health, Toxicology and Mutagenesis (154 citations). K.W. Bock has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Harry Schachter, Jacques Magdalou, Keith F. Tipton, Mitchell Green, Doron Lancet, Alain Bélanger, Pierre Louisot, Takashi Iyanagi, Daniel W. Nebert and Ida S. Owens. Their work appears in journals such as Carcinogenesis, Toxicology Letters, Journal of Cancer Research and Clinical Oncology, Naunyn-Schmiedeberg s Archives of Pharmacology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.